BioCentury | Sep 25, 2020
Emerging Company Profile

XWPharma: timing therapy to biological rhythm

...associated with marketed agents.Last week, XWPharma, formerly XW Laboratories Inc....
BioCentury | Sep 22, 2020
Finance

Sept. 21 Quick Takes: venture funding for Novellus, Immune Regulation, XWPharma and CoreMap

...patients with autoimmune or allergic diseases.XWPharma raises $40M series CChinese neurology company XWPharma Inc. (formerly XW Laboratories Inc....
BioCentury | Sep 10, 2018
Company News

Management tracks: PolarityTE, Medivir

...hired Michael Milburn as CSO. He was CSO of Metabolon Inc. (Morrisville, N.C.). Neurology company XW Laboratories Inc....
BioCentury | Sep 22, 2017
Financial News

XW Labs raises $17.5M in series B

...On Sept. 20, XW Laboratories Inc. (Wuhan, China) said it raised $17.5 million in a series B round...
...which "improve the pharmacokinetics and safety profiles of existing drugs" (see BioCentury, March 24 ). XW Laboratories Inc....
BioCentury | Sep 20, 2017
Financial News

XW Labs raises $17.5M series B

XW Laboratories Inc. (Wuhan, China) said it raised $17.5 million in a series B round led by Elements Capital and WI Harper. New Korean investor KTB Network and all existing investors comprised of Kleiner Perkins...
BioCentury | Mar 24, 2017
Company News

University of Pittsburgh, XW Laboratories deal

...questions to XW, which declined to disclose financial details. University of Pittsburgh , Pittsburgh, Pa. XW Laboratories Inc....
BioCentury | Mar 9, 2017
Finance

Pharmas learn their A, B, seeds

...a pH-dependent anti- PD-L1 antibody. WuXi’s portfolio also contains a handful of Chinese companies, including XW Laboratories Inc....
...Tokyo:4502), Osaka, Japan Tizona Therapeutics Inc., South San Francisco, Calif. University of Minnesota, Minneapolis, Minn. XW Laboratories Inc....
Items per page:
1 - 7 of 7
BioCentury | Sep 25, 2020
Emerging Company Profile

XWPharma: timing therapy to biological rhythm

...associated with marketed agents.Last week, XWPharma, formerly XW Laboratories Inc....
BioCentury | Sep 22, 2020
Finance

Sept. 21 Quick Takes: venture funding for Novellus, Immune Regulation, XWPharma and CoreMap

...patients with autoimmune or allergic diseases.XWPharma raises $40M series CChinese neurology company XWPharma Inc. (formerly XW Laboratories Inc....
BioCentury | Sep 10, 2018
Company News

Management tracks: PolarityTE, Medivir

...hired Michael Milburn as CSO. He was CSO of Metabolon Inc. (Morrisville, N.C.). Neurology company XW Laboratories Inc....
BioCentury | Sep 22, 2017
Financial News

XW Labs raises $17.5M in series B

...On Sept. 20, XW Laboratories Inc. (Wuhan, China) said it raised $17.5 million in a series B round...
...which "improve the pharmacokinetics and safety profiles of existing drugs" (see BioCentury, March 24 ). XW Laboratories Inc....
BioCentury | Sep 20, 2017
Financial News

XW Labs raises $17.5M series B

XW Laboratories Inc. (Wuhan, China) said it raised $17.5 million in a series B round led by Elements Capital and WI Harper. New Korean investor KTB Network and all existing investors comprised of Kleiner Perkins...
BioCentury | Mar 24, 2017
Company News

University of Pittsburgh, XW Laboratories deal

...questions to XW, which declined to disclose financial details. University of Pittsburgh , Pittsburgh, Pa. XW Laboratories Inc....
BioCentury | Mar 9, 2017
Finance

Pharmas learn their A, B, seeds

...a pH-dependent anti- PD-L1 antibody. WuXi’s portfolio also contains a handful of Chinese companies, including XW Laboratories Inc....
...Tokyo:4502), Osaka, Japan Tizona Therapeutics Inc., South San Francisco, Calif. University of Minnesota, Minneapolis, Minn. XW Laboratories Inc....
Items per page:
1 - 7 of 7